Document is current
Any future updates will be listed below
-
Authors
Obradovich, Nick
Khalsa, Sahib S. https://orcid.org/0000-0003-2124-8585
Khan, Waqas U.
Suh, Jina https://orcid.org/0000-0002-7646-5563
Perlis, Roy H.
Ajilore, Olusola https://orcid.org/0000-0003-0737-0437
Paulus, Martin P. https://orcid.org/0000-0002-0825-3606
-
Funding
Funding for this research was provided by:
The William K. Warren Foundation
- License Information
-
More Information
Article History
Received: 25 March 2024
Revised: 26 April 2024
Accepted: 6 May 2024
First Online: 24 May 2024
Competing interests
: Dr. Obradovich is part of OpenAI’s Researcher Access Program and has received resources from OpenAI to support research activities outside of this work. Dr. Khalsa provides uncompensated service on executive boards of the International Society for Contemplative Research and the Float Research Collective, serves on the editorial boards of Biological Psychology and JMIR Mental Health, and has served on a scientific advisory board for Janssen Pharmaceuticals. Dr. Khan has no conflicts of interest or disclosures to make that are relevant to the content. Dr. Suh is employed by Microsoft Research. Dr. Perlis has served on scientific advisory boards for Circular Genomics, Genomind, Belle Artificial Intelligence, Swan AI Studios, and Psy Therapeutics. Dr. Ajilore is the co-founder of KeyWise AI and has served as a consultant for Otsuka Pharmaceuticals on the advisory boards for Sage Therapeutics, Embodied Labs, and Blueprint Health. Dr. Paulus advises Spring Care, Inc., receives royalties from an article on methamphetamine in UpToDate, and has a compensated consulting agreement with Boehringer Ingelheim International GmbH.
